Table 2.
Treatment of hyperkalemia
Mechanism of action | Therapy | Dose and administration | Onset/duration |
---|---|---|---|
I. Membrane stabilization (cardiac injury) | Calcium: calcium gluconate 10 % | 10 ml iv in 2–5 min | 5–10 min/30–60 min |
II. Shift of potassium intracellularly | Insulin + glucose | 10U regular insulin iv + 50 g of glucose (500 ml 10 % or 50 ml 50 % (Glucosmon®) iv | 15–30 min/6–8 h |
β2-adrenergic agonist: salbutamol | 0.5 mg 100 ml glucose 5 % in 15 min iv 10–20 mg (2–4 ml) nebulized in 10 min | 5–8 min/2–3 h | |
Sodium bicarbonate (especially in acidemia) | Bicarbonate 1/6 M, 250–500 ml or 50 ml 1 M iv | 30–60 min/6–8 h | |
II. Removal of potassium | Chelating agents: sodium or calcium polystyrene sulfone | Oral:15–50 g/4–6 h (3–6 spoons with water) | 1 h/4–6 h |
Enema: 30–100 g/4–6 h (dissolved in 250 ml) | 1 h/12 h | ||
Loop diuretic: furosemide, torasemide | 40–200 mg iv 10–100 mg iv with control of renal function | 30 min/8 h | |
Dialysis | 2–3 h | Immediate/duration of dialysis |